Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
19,030,753
-
Share change
-
-2,717,051
-
Total reported value
-
$625,717,799
-
Put/Call ratio
-
113%
-
Price per share
-
$32.96
-
Number of holders
-
165
-
Value change
-
-$187,658,523
-
Number of buys
-
97
-
Number of sells
-
73
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2021
As of 30 Sep 2021 Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) had 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,030,753 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RTW INVESTMENTS, LP, IRIDIAN ASSET MANAGEMENT LLC/CT, ALETHEA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Bellevue Group AG, BAKER BROS. ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and Nuveen Asset Management, LLC.
This table shows 165 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.